if (!window.AdButler){(function(){var s = document.createElement(“script”); s.async = true; s.type = “text/javascript”;s.src = ‘http://ab169825.adbutler-ikon.com/app.js’;var n = document.getElementsByTagName(“script”)[0]; n.parentNode.insertBefore(s, n);}());}
var AdButler = AdButler || {}; AdButler.ads = AdButler.ads || [];
var abkw = window.abkw || ”;
var plc278489 = window.plc278489 || 0;
document.write(‘‘);
AdButler.ads.push({handler: function(opt){ AdButler.register(169825, 278489, [650,211], ‘placement_278489_’+opt.place, opt); }, opt: { place: plc278489++, keywords: abkw, domain: ‘ab169825.adbutler-ikon.com’, click:’CLICK_MACRO_PLACEHOLDER’ }});
11 Sunday / October 11, 2015
05:55 am to 08:00 pm on Oct 15
Los Angeles
http://www.omicsonline.org/pharmacoeconomics-open-access.php
Cost–benefit analysis (CBA) is a systematic approach to estimating the strengths and weaknesses of alternatives that satisfy transactions, activities or functional requirements for a business. Cost Benefit Analysis (CBA) estimates and totals up the equivalent money value of the benefits and costs to the community of projects to establish whether they are worthwhile.
For more information contact:
Kenneth Stokes
[email protected]
